Statistics

Total Visits

Views
Regional analysis of a cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mcrpc) previously treated with docetaxel49

Select a period of time:

Number of views in the range

Views
Regional analysis of a cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mcrpc) previously treated with docetaxel18

Views

Views
July 202511
August 20250
September 20251
October 20250
November 20251
December 20253
January 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil7
United States5
Ecuador1
United Kingdom1
Poland1
Paraguay1
Senegal1
Turkey1
 

Top cities views

Views
San Jose2
Antalya1
Blumenau1
Brusque1
Campos dos Goytacazes1
Cayambe1
Dakar1
Dallas1
Dudley1
Grand Prairie1